Cleared Traditional

K161548 - Osseointegrated Fixtures

K161548 is an FDA 510(k) clearance for Osseointegrated Fixtures, manufactured by Southern Implants (Pty), Ltd.. The device is a Class 2 General & Plastic Surgery device with product code FZE cleared through the Traditional 510(k) pathway after a 181-day FDA review.

K161548 · Southern Implants (Pty), Ltd. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2016
Decision
181d
Days
Class 2
Risk

K161548 is an FDA 510(k) clearance for the Osseointegrated Fixtures. Classified as Prosthesis, Nose, Internal (product code FZE), Class II - Special Controls.

Submitted by Southern Implants (Pty), Ltd. (Irene, ZA). The FDA issued a Cleared decision on December 1, 2016 after a review of 181 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.3680 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Southern Implants (Pty), Ltd. devices

FDA 510(k) Submission Details - K161548

510(k) Number K161548 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 03, 2016
Decision Date December 01, 2016
Days to Decision 181 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
66d slower than avg
Panel avg: 115d · This submission: 181d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FZE Device Classification - Class 2, Special Controls

Product Code FZE Prosthesis, Nose, Internal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.3680
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Consultant

Smith Associates
E.J. SMITH

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - FZE Prosthesis, Nose, Internal

All 27
Devices cleared under the same product code (FZE) and FDA review panel - the closest regulatory comparables to K161548.
Medicon Epiplating System
K241253 · Cmf Medicon Surgical, Inc. · Dec 2024
HANSON MEDICAL FACIAL IMPLANTS
K090803 · Hanson Medical, Inc. · Jun 2010
NOBEL BIOCARE ENDOSSEOUS IMPLANTS (MAXILLOFACIAL INDICATION)
K090630 · Nobel Biocare AB · Jun 2009
MONARCH NASAL IMPLANT
K071018 · Hanson Medical, Inc. · May 2007
MONARCH NASAL IMPLANT
K041690 · Hanson Medical, Inc. · Feb 2005
AART NASAL IMPLANT
K021418 · Aesthetic and Reconstructive Technologies, Inc. · Jul 2002